Meghna Jani Selected Research

Therapeutics

1/2024	Psoriatic arthritis: the role of self-reported non-adherence, non-trough drug levels, immunogenicity and conventional synthetic DMARD co-therapy in adalimumab and etanercept response.
11/2018	Drug safety and immunogenicity of tumour necrosis factor inhibitors: the story so far.
2/2018	Frequent discussion of insomnia and weight gain with glucocorticoid therapy: An analysis of Twitter posts.
1/2018	Erratum: Author Correction: Frequent discussion of insomnia and weight gain with glucocorticoid therapy: an analysis of Twitter posts.
12/2017	Practical Management of Respiratory Comorbidities in Patients with Rheumatoid Arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meghna Jani Research Topics

Disease

14	Rheumatoid Arthritis 07/2023 - 09/2011
6	Psoriatic Arthritis 01/2024 - 07/2015
5	Necrosis 12/2023 - 02/2015
4	Neoplasms (Cancer) 07/2023 - 10/2020
3	Musculoskeletal Diseases (Musculoskeletal Disease) 07/2023 - 11/2018
2	Fibromyalgia (Fibrositis) 07/2023 - 10/2020
2	Infections 10/2022 - 01/2019
2	Cancer Pain 11/2021 - 10/2020
2	Vasculitis (Vasculitides) 11/2018 - 01/2017
2	Weight Gain 02/2018 - 01/2018
2	Sleep Initiation and Maintenance Disorders (Insomnia) 02/2018 - 01/2018
1	Osteoarthritis 07/2023
1	COVID-19 07/2023
1	Axial Spondyloarthritis 07/2023
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2023
1	Joint Diseases (Joint Disease) 11/2022
1	Leukopenia 10/2022
1	Colorectal Neoplasms (Colorectal Cancer) 10/2022
1	Stroke (Strokes) 10/2022
1	Pancytopenia 10/2022
1	Myocardial Infarction 10/2022
1	Body Weight (Weight, Body) 01/2022
1	Hypertension (High Blood Pressure) 01/2021
1	Substance-Related Disorders (Drug Abuse) 10/2020
1	Alcoholism (Alcohol Abuse) 10/2020
1	Synovitis 10/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2019
1	Drug-Related Side Effects and Adverse Reactions 02/2018
1	Pneumonia (Pneumonitis) 12/2017
1	Coinfection 12/2017
1	Rheumatic Diseases (Rheumatism) 05/2015
1	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2014
1	Crohn Disease (Crohn's Disease) 02/2014
1	Cryptococcal Meningitis 09/2011
1	Asthma (Bronchial Asthma) 10/2005

Drug/Important Bio-Agent (IBA)

8	AntibodiesIBA 01/2021 - 02/2014
7	Adalimumab (Humira)FDA Link 01/2024 - 05/2015
6	Etanercept (Enbrel)FDA Link 01/2024 - 05/2015
6	Antirheumatic Agents (DMARD)IBA 01/2024 - 07/2015
6	Opioid Analgesics (Opioids)IBA 07/2023 - 01/2019
4	Tumor Necrosis Factor InhibitorsIBA 12/2023 - 06/2017
4	GlucocorticoidsIBA 01/2021 - 06/2017
3	Infliximab (Remicade)FDA Link 11/2022 - 06/2017
3	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 02/2014
3	Certolizumab Pegol FDA Link 01/2021 - 01/2017
2	MMEIBA 07/2023 - 10/2020
2	golimumab FDA Link 01/2021 - 06/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 05/2015
2	SteroidsIBA 01/2019 - 10/2005
2	tocilizumab (atlizumab)FDA Link 01/2019 - 06/2017
2	Abatacept (Orencia)FDA Link 06/2017 - 03/2012
2	Rituximab (Mabthera)FDA Link 06/2017 - 09/2011
1	GoldIBA 01/2023
1	A 17 (A-17)IBA 01/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	EnzymesIBA 01/2021
1	ImmunosorbentsIBA 01/2021
1	C-Reactive ProteinIBA 10/2020
1	Pharmacological BiomarkersIBA 01/2020
1	InterferonsIBA 06/2019
1	sarilumabIBA 06/2017
1	tofacitinibIBA 06/2017
1	clazakizumabIBA 06/2017
1	Janus KinasesIBA 06/2017
1	baricitinibIBA 06/2017
1	Biosimilar PharmaceuticalsIBA 06/2017
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 06/2017
1	Leflunomide (Arava)FDA LinkGeneric 06/2017
1	Janus Kinase InhibitorsIBA 06/2017
1	sirukumabIBA 06/2017
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 07/2015

Therapy/Procedure

5	Therapeutics 01/2024 - 12/2017
3	Biological Therapy 06/2019 - 05/2014
2	Precision Medicine 11/2022 - 07/2015
1	Aftercare (After-Treatment) 10/2022